Faster global financial news!
Jiangsu Hengrui Medicine
-
Hong Kong-listed biotech firms accelerate Moderna-style cancer vaccine development amid market frenzy
Following Moderna's breakthrough cancer vaccine trial, Chinese companies including Jiangsu Hengrui Pharmaceuticals and Li Ka-shing-backed CK Life Sciences are pushing forward with similar programmes.
-
Hong Kong-listed biotech firms accelerate Moderna-style cancer vaccine development amid market frenzy
Following Moderna's breakthrough cancer vaccine trial, Chinese companies including Jiangsu Hengrui Pharmaceuticals and Li Ka-shing-backed CK Life Sciences are pushing forward with similar programmes.
- No data
Jiangsu Hengrui Medicine
24H Trending
-
1
LAUNCHCOIN: Solana Ecosystem's "One-Click Token Issuance" Platform Analysis and Market Status
-
2
Regulatory Landscape of Virtual Currencies in Mainland China and Risks Associated with Using Overseas Trading Platforms
-
3
According to Bloomberg Markets: Large asset managers are deleveraging in the U.S. Treasury futures market, triggered by forced selling as cash yields approach multi-year highs.
-
4
Wall Street's Rate Shock Spreads Beneath AI-Fueled Market Rally, Driven by High Oil Prices and Borrowing Costs
-
5
BEPR Token Analysis: Distinguishing Between Homonymous Projects and Current Market Status
-
6
TypeSafe AI, the maker of the non-text AI model Jev, reached a valuation of $7.5 billion just weeks after its launch, with a16z leading an $870 million funding round.
-
7
DDX (DerivaDAO) Token Analysis: Mechanism, Utility, and Market Status
-
8
iPhone Vulnerabilities Continue to Threaten Crypto Users, Older iOS Devices Remain at Risk
-
9
SKR Tokenomics Analysis: The Core Driver of the Solana Mobile Ecosystem
-
10
Hungary Needs Significant Deficit Cut For Euro Path, Magyar Says
Markets Today
Recommended Reading
Hot Topics
Svmuu focuses on blockchain industry trends and cutting-edge cryptocurrency news, while also covering real-time market data and in-depth analysis of the Hong Kong, U.S., and foreign exchange markets. Here, you can not only access professional 24/7 news updates and accurate market data, but also utilize practical investment tools to help you capitalize on opportunities in both digital assets and traditional financial markets. Whether you are a blockchain enthusiast or an investor in Hong Kong, U.S., or foreign exchange markets, we provide efficient and timely information services to empower your investment decisions.
- User Agreement
- Privacy Policy
- Contact Us
- Business Partnerships
- Disclaimer
- Content Statement
- About Us
- Sitemap
Coming Soon!
